Which blood type requires an Rhogam (Rho(D) immune globulin) shot, specifically in pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Which Blood Type Requires RhIg (Rhogam)?

Rh-negative (D-negative) pregnant women require RhIg prophylaxis to prevent RhD alloimmunization when carrying or potentially carrying an Rh-positive fetus. 1, 2

Blood Type Specifics

  • Rh-negative women are the only candidates for RhIg administration 1, 3
  • Women who are "weak D" (Du-positive) should NOT receive RhIg as they are considered Rh-positive for clinical purposes 3
  • Women with molecularly defined Asian-type DEL (c.1227G>A) do not require RhIg, as they do not form alloanti-D when exposed to D-positive red cells 4
  • Similarly, women with weak D types 1,2,3,4.0, and 4.1 do not need RhIg prophylaxis 4

Standard Prophylaxis Protocol

Timing and dosing:

  • At 28 weeks gestation: Administer 300 mcg (1500 IU) RhIg to all unsensitized Rh-negative women when fetal blood type is unknown or known to be Rh-positive 1, 5
  • Within 72 hours after delivery: Give 300 mcg (1500 IU) if the infant is Rh-positive 1, 5
  • This two-dose protocol reduces alloimmunization rates from approximately 1.8% to between 0.1% and 0.2% 1

Additional Indications for RhIg in Rh-Negative Women

First trimester events (<12 weeks):

  • Spontaneous or induced abortion: 50 mcg minimum dose (or 300 mcg if 50 mcg unavailable) 1, 5
  • Ectopic pregnancy: 120 mcg minimum 3
  • Threatened abortion with heavy bleeding or abdominal pain 1

After 12 weeks gestation:

  • Miscarriage or abortion: 300 mcg 5, 3
  • Amniocentesis: 300 mcg 5, 3
  • Chorionic villus sampling: 300 mcg 3
  • Cordocentesis: 300 mcg 3
  • Abdominal trauma: 300 mcg 5, 3
  • Placental bleeding or abruption: 300 mcg 1, 3

Dose Adjustments for Large Fetomaternal Hemorrhage

Critical consideration: One standard 300 mcg dose covers up to 15 mL of fetal red blood cells (approximately 30 mL of whole fetal blood) 5

  • If fetomaternal hemorrhage exceeds 15 mL of fetal RBCs, perform quantitative testing (modified Kleihauer-Betke test) 5, 3
  • Calculation: Divide the volume of fetal RBCs by 15 mL to determine the number of 300 mcg doses required 5
  • If the calculation results in a fraction, round up to the next whole number (e.g., if 1.4, give 2 doses) 5
  • For excess hemorrhage, give an additional 10 mcg per 0.5 mL of fetal red blood cells beyond the standard dose coverage 3

Critical Timing Window

The 72-hour window is essential but not absolute:

  • RhIg is most effective when given within 72 hours of exposure 2, 5
  • If not given within 72 hours, administer as soon as recognized, up to 28 days after the sensitizing event 3
  • Delayed administration provides less protection but is still preferable to no administration 1

Common Pitfalls to Avoid

  • Do not assume early pregnancy is safe: Fetal RBCs display D-antigens from as early as 6 weeks gestation, making sensitization possible even in first trimester 1, 2
  • Do not withhold for "minimal" bleeding: Even small volumes (0.03-0.1 mL) of Rh-positive RBCs can trigger alloimmunization 2
  • Do not give RhIg to women who are already sensitized (those with detectable anti-D antibodies) as it provides no benefit 1
  • Do not administer to the neonate - RhIg is only given to the mother 5
  • Do not inject intravenously when using IM preparations 5

Screening Requirements

  • All pregnant women should have blood type and antibody screening at the first prenatal visit and again at 28 weeks 3
  • When paternity is certain, testing the father's Rh status can eliminate unnecessary RhIg administration if he is Rh-negative 3

References

Guideline

Management Guidelines for Rh Negative Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rh Alloimmunization Timeframe and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Prevention of Rh alloimmunization.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.